307 related articles for article (PubMed ID: 16957739)
1. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.
Christophorou MA; Ringshausen I; Finch AJ; Swigart LB; Evan GI
Nature; 2006 Sep; 443(7108):214-7. PubMed ID: 16957739
[TBL] [Abstract][Full Text] [Related]
2. Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas.
Hoogervorst EM; Bruins W; Zwart E; van Oostrom CT; van den Aardweg GJ; Beems RB; van den Berg J; Jacks T; van Steeg H; de Vries A
Cancer Res; 2005 May; 65(9):3610-6. PubMed ID: 15867355
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
[TBL] [Abstract][Full Text] [Related]
4. p53 and tumor suppression.
Van Dyke T
N Engl J Med; 2007 Jan; 356(1):79-81. PubMed ID: 17202460
[No Abstract] [Full Text] [Related]
5. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
De la Cueva E; García-Cao I; Herranz M; López P; García-Palencia P; Flores JM; Serrano M; Fernández-Piqueras J; Martín-Caballero J
Oncogene; 2006 Jul; 25(29):4128-32. PubMed ID: 16462758
[TBL] [Abstract][Full Text] [Related]
6. Genetic dissection of the role of p21Cip1/Waf1 in p53-mediated tumour suppression.
Efeyan A; Collado M; Velasco-Miguel S; Serrano M
Oncogene; 2007 Mar; 26(11):1645-9. PubMed ID: 16964282
[TBL] [Abstract][Full Text] [Related]
7. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
8. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
9. Cancer biology: can less be more for p53?
Berns A
Nature; 2006 Sep; 443(7108):153-4. PubMed ID: 16971934
[No Abstract] [Full Text] [Related]
10. Functional interplay of p53 and Mus81 in DNA damage responses and cancer.
Pamidi A; Cardoso R; Hakem A; Matysiak-Zablocki E; Poonepalli A; Tamblyn L; Perez-Ordonez B; Hande MP; Sanchez O; Hakem R
Cancer Res; 2007 Sep; 67(18):8527-35. PubMed ID: 17875692
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice.
Lee JM; Abrahamson JL; Kandel R; Donehower LA; Bernstein A
Oncogene; 1994 Dec; 9(12):3731-6. PubMed ID: 7970733
[TBL] [Abstract][Full Text] [Related]
12. Tripeptidyl peptidase II plays a role in the radiation response of selected primary cell types but not based on nuclear translocation and p53 stabilization.
Firat E; Tsurumi C; Gaedicke S; Huai J; Niedermann G
Cancer Res; 2009 Apr; 69(8):3325-31. PubMed ID: 19351849
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of the p53 response to DNA damage by high cell density.
Bar J; Cohen-Noyman E; Geiger B; Oren M
Oncogene; 2004 Mar; 23(12):2128-37. PubMed ID: 14755247
[TBL] [Abstract][Full Text] [Related]
14. p53 modulation of the DNA damage response.
Helton ES; Chen X
J Cell Biochem; 2007 Mar; 100(4):883-96. PubMed ID: 17031865
[TBL] [Abstract][Full Text] [Related]
15. Modeling the therapeutic efficacy of p53 restoration in tumors.
Martins CP; Brown-Swigart L; Evan GI
Cell; 2006 Dec; 127(7):1323-34. PubMed ID: 17182091
[TBL] [Abstract][Full Text] [Related]
16. Ongoing activation of p53 pathway responses is a long-term consequence of radiation exposure in vivo and associates with altered macrophage activities.
Coates PJ; Robinson JI; Lorimore SA; Wright EG
J Pathol; 2008 Apr; 214(5):610-6. PubMed ID: 18266203
[TBL] [Abstract][Full Text] [Related]
17. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
[TBL] [Abstract][Full Text] [Related]
18. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
[TBL] [Abstract][Full Text] [Related]
19. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
20. In vivo bystander effect: cranial X-irradiation leads to elevated DNA damage, altered cellular proliferation and apoptosis, and increased p53 levels in shielded spleen.
Koturbash I; Loree J; Kutanzi K; Koganow C; Pogribny I; Kovalchuk O
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):554-62. PubMed ID: 18207032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
